Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma

Acta Urologica Japonica

Volumn 42, Issue 4, 1996, Pages 257-261

  Mori, Hirotaka ^a   Miyaji, Bunya ^a   Takahashi, Masahiko ^a   Matsuda, Kaori ^a   Tsuka, Harutoshi ^a   Wada, Osamu ^a   Aoki, Yoshitaka ^a   Akino, Hironobu ^a   Muranaka, Kouji ^a   Kanamaru, Hiroshi ^a   Okada, Ken Ichiro ^a   Imamura, Yoshiaki ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

BCG; upper tract transitional cell carcinoma

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FEVER; HUMAN; MALE; SEPSIS; TRANSITIONAL CELL CARCINOMA; URETER STRICTURE; URINARY TRACT CARCINOMA;

AGED; AGED, 80 AND OVER; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; UROLOGIC NEOPLASMS;

EID: 15844384989     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Morales A, Eidinger D and Bruce AW: Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116: 180-183, 1976
2. Studer UE, Casanova G, Kraft R, et al.: Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. J Urol 142: 975-977, 1989
3. Sharpe JR, Dufiy G and Chin JL: Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol 149: 457-460, 1993
4. Herr HW: Durable response of a carcinoma in situ of the renal pelvis to topical bacillus CalmetteGuerin. J Urol 134: 531-532, 1985
5. Smith AD, Orihuela E and Crowley AR: Percutaneous management of renal pelvic tumors : a treatment option in selected cases. J Urol 137: 852-856, 1987
6. Lamm DL, van der Meijden APM, Morales A, et al.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147: 596-600, 1992
7. Ramsey JC and Soloway MS: Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. J Urol 143: 1220-1222, 1990
8. Schoenberg MP, van Arsdalen KN and Wein AJ: The management of transitional cell carcinoma in solitary renal units. J Urol 146: 700-703, 1991
9. Bellman GC, Sweetser P and Smith AD: Complications of intracavitary bacillus CalmetteGuerin after percutaneous resection of upper tract transitional cell carcinoma. J Urol 151: 13-15, 1994
10. Fishman JR, Walton DT, Flynn NW, et al.: Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy. J Urol 149: 584-587, 1993
11. Rawls WH, Lamm DL, Lowe BA, et al. : Fatal sepsis following intravesical bacillus CalmetteGuerin administration for bladder cancer. J Urol 144: 1328-1330, 1990
12. Mukamel E, Layfield LJ, Hawkins RA, et al. : The effect of bacillus Calmette-Guerin on the urinary system of pigs. J Urol 139: 165-169, 1988